UMIN ID: UMIN000001402
Registered date:30/09/2008
Jikei-comparison of Lantus and Levemir with CGM for thinking insulin optimization
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | type 1 diabetes |
| Date of first enrollment | 2008/05/01 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Detemir Glargine |
Outcome(s)
| Primary Outcome | Continuous glucose value of 24 hours by CGM |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Type 2 diabetes. |
Related Information
| Primary Sponsor | The Jikei University School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | donation |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| ms97-tsujino@jikei.ac.jp | |
| Affiliation | The Jikei University School of Medicine Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine |
| scientific contact | |
| Name | Daisuke Tsujino |
| Address | 3-25-8 Nishishinbashi, Minato-ku, Tokyo,Japan Japan |
| Telephone | |
| Affiliation | The Jikei University School of Medicine Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine |